Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person6
Paradigm Biocapital Advisors LP
Company
Anchorage Capital Advisors, L.P.
Company
Encompass Capital Advisors LLC
Company
BAKER BROS. ADVISORS LP
Company
INFRASTRUCTURE CAPITAL ADVISORS, LLC
Company
WASATCH ADVISORS LP
Company
Primary record9
Paradigm Biocapital Advisors LP filed SCHEDULE 13G
0001104659-26-113688.txt : 20261005 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001855655 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 09/28/2026 0002130606 Obsidian Therapeutics, Inc. 67448A106 1030 Ma
Paradigm Biocapital Advisors LP filed SCHEDULE 13G
0001104659-26-112828.txt : 20261001 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001855655 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 09/24/2026 0001636282 Spyre Therapeutics, Inc. 00773J202 221 Cresce
Paradigm Biocapital Advisors LP filed SCHEDULE 13G
0001104659-26-108569.txt : 20260917 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001855655 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 09/10/2026 0001863127 Tyra Biosciences, Inc. 90240B106 2656 State S
Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A
0001104659-26-097208.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 1 Common Stock, $0.01 par value per share 06/30/2026 0001590750 Viridian Therapeutics, Inc. 92790C104 221
Maze Therapeutics, Inc. filed SCHEDULE 13G/A
0001104659-26-097205.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 1 Common Stock, $0.001 par value per share 06/30/2026 0001842295 Maze Therapeutics, Inc. 578784100 171 Oy
Edgewise Therapeutics, Inc. filed SCHEDULE 13G/A
0001104659-26-097206.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 2 Common Stock, $0.0001 par value per share 06/30/2026 0001710072 Edgewise Therapeutics, Inc. 28036F105 1
Lexeo Therapeutics, Inc. filed SCHEDULE 13G/A
0001104659-26-097207.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 3 Common Stock, $0.0001 par value per share 06/30/2026 0001907108 Lexeo Therapeutics, Inc. 52886X107 345
Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A
0001104659-26-097210.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 4 Common Stock, $0.001 par value per share 06/30/2026 0001786205 Arcellx, Inc. 03940C100 800 Bridge Parkw
ASSEMBLY BIOSCIENCES, INC. filed SCHEDULE 13G/A
0001104659-26-097209.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001855655 XXXXXXXX LIVE 1 Common Stock, $0.001 par value per share 06/30/2026 0001426800 Assembly Biosciences, Inc. 045396207 Two